ECHDC3 has a role in fatty acid biosynthesis and has been found to have an increased expression in the brains of Alzheimer's patients (25) while USP6NL is a GTPase-activating protein for Rabs and is up-regulated in several cancers, including breast and colorectal cancers (26, 27). Here, ECHDC3 is linked to colorectal cancer.